1st Quarter - Report

FABIANI & COMPANY for MEDRAD, INC

Period 1st Quarter 2011 Filed Apr 19, 2011 Signed by Gary Martin, CFO

Official filing
Firm
FABIANI & COMPANY
Client
MEDRAD, INC
Income
$40,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Provisions in health care reform legislation (including H.R. 3590, the Patient Protection and Affordable Care) pertaining to the medical device excise tax (including S.16, S.193, HR141, HR145, HR215, HR429, HR 636), and 1099 repeal (including S.18, S.72, HR, HR60, HR144, HR584, HR705).

LobbyistCovered position, as disclosed
LINDSAY BOMAR —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 429 (112th), H.R. 60 (112th), S. 72 (112th), H.R. 584 (112th), H.R. 636 (112th), H.R. 141 (112th), S. 18 (112th), S. 16 (112th), H.R. 145 (112th), H.R. 144 (112th), H.R. 215 (112th), H.R. 705 (112th), S. 193 (112th), H.R. 3590 (112th)

Copyright/Patent/Trademark CPT

Provisions of the Patent Reform Act (S. 23 and H.R. 1249).

LobbyistCovered position, as disclosed
LINDSAY BOMAR —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 23 (112th), H.R. 1249 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.